A Mechanistic Basis for Converting a Receptor Tyrosine Kinase Agonist to an Antagonist

doi 10.2210/pdb2qj4/pdb
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Worldwide Protein Data Bank

Related search

Time-Dependent Antagonist-Agonist Switching in Receptor Tyrosine Kinase-Mediated Signaling

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2019English

Receptor Tyrosine Kinase (RTK); VEGF-A

Science-Business eXchange
2014English

Agonist--Antagonist--Muscarinic Receptor Ternary Complex.

Acta Chemica Scandinavica
1980English

Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonist

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2016English

The Neuronal Receptor Tyrosine Kinase Alk Is a Target for Longevity

Aging Cell
AgingCell Biology
2020English

5-Ht3 Receptor Antagonism by Anpirtoline, a Mixed 5-Ht1 Receptor Agonist/5-Ht3 Receptor Antagonist

British Journal of Pharmacology
Pharmacology
1995English

Agonist and Antagonist Recognition by RIG-I, a Cytoplasmic Innate Immunity Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

RYK, a Receptor Tyrosine Kinase-Related Molecule With Unusual Kinase Domain Motifs.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

The Ephrin Receptor Tyrosine Kinase A2 Is a Cellular Receptor for Kaposi's Sarcoma–associated Herpesvirus

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy